Following our recent breakthrough on mouse mini-intestines for ex vivo tumor development, we asked ourselves: can this technology be applied to cells from cancer patients? We are excited to announce the answer to this question in our latest publication: rdcu.be/dMuAr
8
53
337
46,805
This system unlocks exciting experimental possibilities, such as the multi-faceted evaluation of drug efficacy, toxicity and resistance in anti-cancer therapies,
Jul 3, 2024 · 4:35 AM UTC
1
1
11
463
the discovery of a cancer associated fibroblast (CAF)-triggered mechanism driving colorectal cancer invasion,
2
1
11
475
and the identification of immunomodulatory interactions among different components of the tumor microenvironment.
1
1
13
1,865
This work has been led by the brilliant @LFranciscoLM, with invaluable support from @NicoBroguiere, @JakobJLanger, Lucie Tillard, @mike_nikolaev, @CoukosGeorge, and Krisztian Homicsko. 🙏🙏!!
9
1,551


